Trial Profile
Pilot clinical study of bacterial lysate [Ismigen] in patients with chronic obstructive pulmonary disease receiving regular treatment with salmeterol/fluticasone
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs Bacterial lysate (Primary) ; Salmeterol/fluticasone propionate
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 05 Nov 2010 New trial record.